Stockreport

AGC Biologics to Manufacture AAVantgarde's Dual-Vector Gene Therapies for Inherited Retinal Disorders [Yahoo! Finance]

AGC INC UNSP/ADR  (ASGLY) 
PDF MILAN, November 21, 2025 BUSINESS WIRE )--On the heels of AAVantgarde closing a Series B financing round , AGC Biologics announced a new manufacturing agreement with the [Read more]